Sarcospan reduces dystrophic pathology: Stabilization of the utrophin-glycoprotein complex

Journal of Cell Biology

Volumn 183, Issue 3, 2008, Pages 419-427

  Peter, Angela K ^a   Marshall, Jamie L ^a   Crosbie, Rachelle H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; GLYCOPROTEIN; MEMBRANE PROTEIN; SARCOSPAN; TETRASPANIN; UNCLASSIFIED DRUG; UTROPHIN; CARRIER PROTEIN; SSPN PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE LOSS; GENE MUTATION; MALE; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SARCOLEMMA; SYNAPTIC MEMBRANE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; TRANSGENIC MOUSE;

MUS;

ANIMALS; CARRIER PROTEINS; DYSTROPHIN; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NEOPLASM PROTEINS; SARCOLEMMA; TRANSCRIPTION, GENETIC; UTROPHIN;

EID: 56149099711     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200808027     Document Type: Article

References (34)

1. Barresi, R., and K.P. Campbell. 2006. Dystroglycan: from biosynthesis to pathogenesis of human disease.J. Cell Sci. 119:199-207.
2. Campbell, K.P., and S.D. Kahl. 1989. Association of dystrophin and an integral membrane glycoprotein. Nature. 338:259-262.
3. Crawford, G.E., J.A. Faulkner, R.H. Crosbie, K.P. Campbell, S.C. Froehner, and J.S. Chamberlain. 2000. Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J. Cell Biol. 150:1399-1410.
4. Crosbie, R.H., J. Heighway, D.P Venzke, J.C. Lee, and K.P. Campbell. 1997. Sarcospan: the 25-kDa transmembrane component of the dystrophinglycoprotein complex. J. Biol. Chem. 272:31221-31224.
5. Crosbie, R.H., H. Yamada, D.P. Venzke, M.P Lisanti, and K.P. Campbell. 1998. Caveolin-3 is not an integral component of the dystrophin-glycoprotein complex. FEBS Lett. 427:279-282.
6. Crosbie, R.H., C.S. Lebakken, K.H. Holt, D.P. Venzke, V. Straub, J.C. Lee, R.M. Grady, J.S. Chamberlain, J.R. Sanes, and K.P. Campbell. 1999. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex.J. Cell Biol. 145:153-165.
7. DelloRusso, C., J.M. Scott, D. Hartigan-O'Connor, G. Salvatori, C. Barjot, A.S. Robinson, R.W. Crawford, S.V Brooks, and J.S. Chamberlain. 2002. Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc Natl. Acad. Sci. USA. 99:12979-12984.
8. Durbeej, M., and K.P. Campbell. 2002. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev. 12:349-361.
9. Ervasti, J.M., and K.P. Campbell. 1991. Membrane organization of the dystrophin-glycoprotein complex. Cell. 66:1121-1131.
10. Ervasti, J.M., and K.P. Campbell. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:809-823.
11. Ervasti, J.M., K. Ohlendieck, S.D. Kahl, M.G. Gaver, and K.P. Campbell. 1990. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 345:315-319.
12. Ervasti, J.M., S.D. Kahl, and K.P. Campbell. 1991. Purification of dystrophin from skeletal muscle. J. Biol. Chem. 266:9161-9165.
13. Grady, R.M., H. Zhou, J.M. Cunningham, M.D. Henry, K.P. Campbell, and J.R. Sanes. 2000. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron. 25:279-293.
14. Gregorevic, P., J.M. Allen, E. Minami, M.J. Blankinship, M. Haraguchi, L. Meuse, E. Finn, M.E. Adams, S.C. Froehner, C.E. Murry, and J.S. Chamberlain. 2006. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat. Med. 12:787-789.
15. Hemler, M.E. 2003. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19:397-422.
16. Holt, K.H., and K.P. Campbell. 1998. Assembly of the sarcoglycan complex. Insights for muscular dystrophy. J. Biol. Chem. 273:34667-34670.
17. Jasmin, B.J., H. Alameddine, J.A. Lunde, F Stetzkowski-Marden, H. Collin, J.M. Tinsley, K.E. Davies, FM. Tome, D.J. Parry, and J. Cartaud. 1995. Expression of utrophin and its mRNA in denervated mdx mouse muscle. FEBS Lett. 374:393-398.
18. Judge, L.M., M. Haraguchiln, and J.S. Chamberlain. 2006. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex. J. Cell Sci. 119:1537-1546.
19. Levy, S., and T. Shoham. 2005. The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5:136-148.
20. Matsumura, K., J.M. Ervasti, K. Ohlendieck, S.D. Kahl, and K.P. Campbell. 1992. Association of dystrophin-related protein with dystrophin-associated proteins in max mouse muscle. Nature. 360:588-591.
21. Menke, A., and H. Jockusch. 1991. Decreased osmotic stability of dystrophinless muscle cells from the mdx mouse. Nature. 349:69-71.
22. Michele, D.E., and K.P. Campbell. 2003. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem. 278:15457-15460.
23. Miller, G., E.L. Wang, K.L. Nassar, A.K. Peter, and R.H. Crosbie. 2007. Structural and functional analysis of the sarcoglycan-sarcospan subcomplex. Exp. Cell Res. 313:639-651.
24. Odom, G.L., P. Gregorevic, and J.S. Chamberlain. 2007. Viral-mediated gene therapy for the muscular dystrophies: successes, limitations, and recent advances. Biochim. Biophys. Acta. 1772:243-262.
25. Ohlendieck, K., and K.P. Campbell. 1991. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell Biol. 115: 1685-1694.
26. Peter, A.K., and R.H. Crosbie. 2006. Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway. Exp. Cell Res. 312:2580-2591.
27. Peter, A.K., G. Miller, and R.H. Crosbie. 2007. Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice. J. Cell Sci. 120:996-1008.
28. Petrof, B.J., J.B. Shrager, H.H. Stedman, A.M. Kelly, and H.L. Sweeney. 1993. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA. 90:3710-3714.
29. Spencer, M.J., J.R. Guyon, H. Sorimachi, A. Potts, I. Richard, M. Herasse, J. Chamberlain, I. Dalkilic, L.M. Kunkel, and J.S. Beckmann. 2002. Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation. Proc. Natl. Acad. Sci. USA. 99:8874-8879.
30. Straub, V, J.A. Rafael, J.S. Chamberlain, and K.P. Campbell. 1997. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139:375-385.
31. Tinsley, J.M., A.C. Potter, S.R. Phelps, R. Fisher, J.I. Trickett, and K.E. Davies. 1996. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature. 384:349-353.
32. Tinsley, J., N. Deconinck, R. Risher, D. Kahn, S. Phelps, J.M. Gillis, and K. Davies. 1998. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat. Med. 4:1441-1444.
33. Weller, B., G. Karpati, and S. Carpenter. 1990. Dystrophin-dencient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci. 100:9-13.
34. Yoshida, M., and E. Ozawa. 1990. Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. (Tokyo). 108:748-752.